MCPHY ENERGY SA (MCPHY.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:MCPHY • FR0011742329

2.32 EUR
+0 (+0.22%)
Last: Aug 8, 2024, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MCPHY. MCPHY was compared to 112 industry peers in the Machinery industry. MCPHY may be in some trouble as it scores bad on both profitability and health. MCPHY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • MCPHY had negative earnings in the past year.
  • In the past year MCPHY has reported a negative cash flow from operations.
  • MCPHY had negative earnings in each of the past 5 years.
  • In the past 5 years MCPHY always reported negative operating cash flow.
MCPHY.PA Yearly Net Income VS EBIT VS OCF VS FCFMCPHY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M

1.2 Ratios

  • MCPHY's Return On Assets of -28.85% is on the low side compared to the rest of the industry. MCPHY is outperformed by 94.50% of its industry peers.
  • With a Return On Equity value of -53.75%, MCPHY is not doing good in the industry: 90.83% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -28.85%
ROE -53.75%
ROIC N/A
ROA(3y)-19.55%
ROA(5y)-16.85%
ROE(3y)-31.9%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
MCPHY.PA Yearly ROA, ROE, ROICMCPHY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80 -100

1.3 Margins

  • MCPHY has a Gross Margin of 14.75%. This is amonst the worse of the industry: MCPHY underperforms 90.83% of its industry peers.
  • In the last couple of years the Gross Margin of MCPHY has declined.
  • MCPHY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.69%
GM growth 5Y-19.17%
MCPHY.PA Yearly Profit, Operating, Gross MarginsMCPHY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • MCPHY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, MCPHY has about the same amount of shares outstanding.
  • Compared to 1 year ago, MCPHY has a worse debt to assets ratio.
MCPHY.PA Yearly Shares OutstandingMCPHY.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MCPHY.PA Yearly Total Debt VS Total AssetsMCPHY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -0.85, we must say that MCPHY is in the distress zone and has some risk of bankruptcy.
  • MCPHY has a Altman-Z score of -0.85. This is amonst the worse of the industry: MCPHY underperforms 81.65% of its industry peers.
  • MCPHY has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • MCPHY has a Debt to Equity ratio of 0.03. This is amongst the best in the industry. MCPHY outperforms 90.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -0.85
ROIC/WACCN/A
WACC7.47%
MCPHY.PA Yearly LT Debt VS Equity VS FCFMCPHY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that MCPHY should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, MCPHY is in line with its industry, outperforming 53.21% of the companies in the same industry.
  • MCPHY has a Quick Ratio of 1.43. This is a normal value and indicates that MCPHY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of MCPHY (1.43) is better than 74.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.43
MCPHY.PA Yearly Current Assets VS Current LiabilitesMCPHY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • MCPHY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.41%.
  • MCPHY shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.89%.
  • Measured over the past years, MCPHY shows a quite strong growth in Revenue. The Revenue has been growing by 18.75% on average per year.
EPS 1Y (TTM)-24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.49%
Revenue 1Y (TTM)16.89%
Revenue growth 3Y11.09%
Revenue growth 5Y18.75%
Sales Q2Q%8.25%

3.2 Future

  • MCPHY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.79% yearly.
  • The Revenue is expected to grow by 51.36% on average over the next years. This is a very strong growth
EPS Next Y-2.53%
EPS Next 2Y8.21%
EPS Next 3Y14.96%
EPS Next 5Y22.79%
Revenue Next Year66.02%
Revenue Next 2Y72.07%
Revenue Next 3Y95.14%
Revenue Next 5Y51.36%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCPHY.PA Yearly Revenue VS EstimatesMCPHY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
MCPHY.PA Yearly EPS VS EstimatesMCPHY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MCPHY. In the last year negative earnings were reported.
  • Also next year MCPHY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MCPHY.PA Price Earnings VS Forward Price EarningsMCPHY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MCPHY.PA Per share dataMCPHY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

  • MCPHY's earnings are expected to grow with 14.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.21%
EPS Next 3Y14.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MCPHY!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

MCPHY ENERGY SA

EPA:MCPHY (8/8/2024, 7:00:00 PM)

2.32

+0 (+0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)07-30
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap67.60M
Revenue(TTM)18.77M
Net Income(TTM)-47.43M
Analysts41.82
Price Target3 (29.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.96%
PT rev (3m)-39.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.31%
EPS NY rev (3m)-0.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)31.66%
Revenue NY rev (3m)31.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.6
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-1.7
EYN/A
EPS(NY)-1.69
Fwd EYN/A
FCF(TTM)-2.55
FCFYN/A
OCF(TTM)-1.76
OCFYN/A
SpS0.64
BVpS3.03
TBVpS2.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -28.85%
ROE -53.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.75%
FCFM N/A
ROA(3y)-19.55%
ROA(5y)-16.85%
ROE(3y)-31.9%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-31.69%
GM growth 5Y-19.17%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 412.64%
Cap/Sales 121.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.43
Altman-Z -0.85
F-Score3
WACC7.47%
ROIC/WACCN/A
Cap/Depr(3y)378.1%
Cap/Depr(5y)233.61%
Cap/Sales(3y)63.29%
Cap/Sales(5y)38.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29.49%
EPS Next Y-2.53%
EPS Next 2Y8.21%
EPS Next 3Y14.96%
EPS Next 5Y22.79%
Revenue 1Y (TTM)16.89%
Revenue growth 3Y11.09%
Revenue growth 5Y18.75%
Sales Q2Q%8.25%
Revenue Next Year66.02%
Revenue Next 2Y72.07%
Revenue Next 3Y95.14%
Revenue Next 5Y51.36%
EBIT growth 1Y-30.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.4%
EBIT Next 3Y20.22%
EBIT Next 5Y17.79%
FCF growth 1Y-187.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-205.02%
OCF growth 3YN/A
OCF growth 5YN/A

MCPHY ENERGY SA / MCPHY.PA FAQ

Can you provide the ChartMill fundamental rating for MCPHY ENERGY SA?

ChartMill assigns a fundamental rating of 2 / 10 to MCPHY.PA.


Can you provide the valuation status for MCPHY ENERGY SA?

ChartMill assigns a valuation rating of 0 / 10 to MCPHY ENERGY SA (MCPHY.PA). This can be considered as Overvalued.


Can you provide the profitability details for MCPHY ENERGY SA?

MCPHY ENERGY SA (MCPHY.PA) has a profitability rating of 0 / 10.


What is the financial health of MCPHY ENERGY SA (MCPHY.PA) stock?

The financial health rating of MCPHY ENERGY SA (MCPHY.PA) is 3 / 10.


Can you provide the expected EPS growth for MCPHY stock?

The Earnings per Share (EPS) of MCPHY ENERGY SA (MCPHY.PA) is expected to decline by -2.53% in the next year.